BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

Concurrent Pharmaceuticals 

One Broadway, 14th Floor

Cambridge  Massachusetts  02142  U.S.A.
Phone: 617-475-1521 Fax: 617-621-0496


SEARCH JOBS


Industry
Pharmaceutical

Segment
Start Up





 Company News
Champions Biotechnology, Inc. (CSBR) and Concurrent Pharmaceuticals Establish Royalty Agreement for Novel Oncology Drug 1/12/2009 10:03:10 AM    More...
Concurrent Pharmaceuticals Changes Name To Vitae Pharmaceuticals And Secures $34 Million In Financing 10/19/2005 5:11:34 PM    More...
Concurrent Pharmaceuticals Acquires Rights To Allergan Inc. (AGN) Retinoid Portfolio To Accelerate Drug Development Programs -- Concurrent Progresses To Integrated Drug Discovery And Development Company With Preclinical Candidates In Four Major Therapeutic Areas 10/19/2005 5:11:31 PM    More...
Concurrent Pharmaceuticals Appoints Jeffrey Hatfield As Chief Executive Officer 10/19/2005 5:11:27 PM    More...
Concurrent Pharmaceuticals Announces $15 Million Private Financing, Collaboration With Intel In Machine Learning For Drug Discovery, And Rapid Progress On Renin Inhibitor Program 10/19/2005 5:09:39 PM    More...

//-->